Posted on 4/28/17
Better Buy: Ionis Pharmaceuticals, Inc. vs. bluebird bio
The most promising biotechs have productive platforms and are pioneering new approaches to treating conditions difficult to address with conventional therapies. Two that fit that bill . . .
Posted on 4/28/17
Medullan Attains ISO 27001 Certification for Information Security Management
Medullan, a digital health firm that designs and builds powerful solutions that achieve high rates of adoption in the payer, life sciences and pharmaceutical industries, announced . . .
Posted on 4/27/17
Better Buy: Amgen Inc. vs. Biogen
If you're looking for unusually high returns on your capital, biotechnology remains a fairly safe bet, even despite its monstrous run-up over the past five years. . . .
Posted on 4/27/17
Biogen Inc. Earnings: New Drug Sparks Life
Biogen (NASDAQ:BIIB) reported first-quarter earnings on Tuesday, resulting in investors excited about the potential for Spinraza, its new spinal muscular atrophy drug developed with Ionis Pharmaceuticals . . .
Posted on 4/27/17
SRG WOOLF Opens New Boston Office
BOSTON--(BUSINESS WIRE)--SRG Woolf, a leading provider of clinical research staffing solutions, today announced the opening of a new office location in Boston – expanding its footprint . . .
Posted on 4/26/17
Peak Physical Therapy & Sports Performance Provides Fall Prevention Program at the Allerton House in Hingham
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide a comprehensive approach to treatment in orthopedic, spine and sports . . .
Posted on 4/26/17
Thermo Fisher Scientific Reports First Quarter 2017 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 1, 2017.First Quarter . . .
Posted on 4/26/17
Agios Announces Exercise of Over-Allotment Option in Public Offering
CAMBRIDGE, Mass., April 26, 2017 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced that the underwriters of its previously announced public offering of common stock . . .
Posted on 4/26/17
Xerox (XRX) Q1 2017 Results - Earnings Call Transcript
Xerox Corp. (NYSE:XRX)Q1 2017 Earnings CallApril 25, 2017 10:00 am ETExecutivesJeffrey Jacobson - Xerox Corp.William F. Osbourn - Xerox Corp.Jennifer Horsley - Xerox Corp.AnalystsShannon S. Cross . . .
Posted on 4/26/17
3 Reasons Pfizer Is a Better Dividend Stock Than Bristol-Myers Squibb
Big pharma stocks have been popular among investors seeking solid dividends for a long time. And for good reason: Large drugmakers historically have generated such tremendous . . .
Posted on 4/26/17
Biogen (BIIB) Q1 2017 Results - Earnings Call Transcript
Biogen, Inc. (NASDAQ:BIIB)Q1 2017 Earnings CallApril 25, 2017 8:30 am ETExecutivesMatthew Calistri - Biogen, Inc.Michel Vounatsos - Biogen, Inc.Michael D. Ehlers, M.D., Ph.D. - Biogen, Inc.Paul . . .
Posted on 4/26/17
Biogen: Key Q1 2017 Insights
Biogen (NASDAQ:BIIB) reported Q1 2017 results before the market opened on April 25. The stock then trended up, despite revenue growth since Q1 2016 being anemic.The . . .
Posted on 4/26/17
Biogen and Alzheimer’s: There’s a Fundamental Problem Here
Back in 2015, biotech juggernaut Biogen (NASDAQ:BIIB) made headlines on the news that its investigational Alzheimer's disease (AD) treatment aducanumab showed strong efficacy in an early-stage . . .
Posted on 4/25/17
Alzheon Scientists Discover Novel Therapeutic Mechanism of Inhibition of Formation of Toxic Beta Amyloid Oligomers
Published Data Shows that Novel ‘Enveloping’ Mechanism of Tramiprosate Modulates Misfolding of Aß42 Amyloid and Prevents Oligomer Formation Early in Amyloid Aggregation CascadePharmacokinetic Analyses Confirm Tramiprosate . . .
Posted on 4/25/17
ShopRite Joins Aetna’s Preferred Medicare Pharmacy Network
KEASBEY, N.J. & HARTFORD, Conn.--(BUSINESS WIRE)--ShopRite and Aetna (NYSE: AET) today announced ShopRite has joined Aetna’s national network of preferred pharmacies. Effective immediately, Aetna Medicare members . . .
Posted on 4/24/17
Agios Closes Public Offering
CAMBRIDGE, Mass., April 24, 2017 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced the closing of its previously announced underwritten public offering of 5,050,505 shares . . .
Posted on 4/24/17
Syros Announces $35 Million Private Placement
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company pioneering the discovery and development of medicines to control the expression of disease-driving genes, announced today that it . . .
Posted on 4/21/17
Bristol-Myers Squibb Co: Buy the Dip?
Shares of Bristol-Myers Squibb (NYSE:BMY) have slipped about 30% since the company announced a surprising setback for its lead growth driver, Opdivo, last August. More recent . . .
Posted on 4/21/17
Zillion Health and Vidyo Aim to Simplify Patient Engagement
HACKENSACK, N.J. & NORWALK, Conn.--(BUSINESS WIRE)--Leading video collaboration technology provider Vidyo today announced a new partner in population health management, Zillion® Health, a cutting-edge patient engagement . . .
Posted on 4/21/17
H3 Biomedicine Extends Collaboration with Foundation Medicine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--H3 Biomedicine Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of precision medicines for oncology and a member of Eisai’s . . .
Posted on 4/21/17
Circulation Expands into 700 Health Facilities across 25 States
BOSTON--(BUSINESS WIRE)--Circulation today signaled significant growth in non-emergency medical transportation (NEMT) with the announcement of over 30 new clients representing a broad swath of top-tier hospitals, . . .
Posted on 4/20/17
Peak Physical Therapy & Sports Performance Provides Free Clinic for Quincy Youth Soccer Boys and Girls U14
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive approach to treatment in orthopedic, spine and sports medicine . . .
Posted on 4/20/17
Is Cara Therapeutics About to Change How We Treat Pain?
Cara Therapeutics (NASDAQ:CARA) is working on a new pain-killing drug that works differently than traditional opioids, and that could make it a better option for patients . . .
Posted on 4/20/17
Gentle Dental Partners Has Partnered with Great Hill Dental Partners
Gentle Dental Partners (gentledental.com) has closed an affiliation with Great Hill Dental Partners LLC, adding 5 multi-specialty practices in the Greater Boston area. Great Hill Dental . . .
Posted on 4/19/17
Abbott-Alere Deal To Go Ahead
Abbott Laboratories (NYSE:ABT) has brought down the cost of its acquisition of the diagnostics maker Alere (NYSE:ALR), but some might say that it is still overpaying. . . .
Boston
